Pre-clinical development of a lentiviral gene therapy to treat hearing and balance loss in Usher 1B patients

Project Information

MY-O-SENSES

Grant agreement ID: 101082064

DOI

10.3030/101082064

Project closed

EC signature date 8 August 2022

Start date 1 September 2022

End date 29 February 2024

Funded under

• European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

MEDIZINISCHE HOCHSCHULE HANNOVER
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1B

Author(s): Juliane W Schott, Peixin Huang, Michael Morgan, Jennifer Nelson-Brantley, Ally Koehler, Bryan Renslo, Hildegard Büning, Athanasia Warnecke, Axel Schambach, Hinrich Staecker
Published in: Molecular Therapy, 2023, ISSN 1525-0024
Publisher: Cell Press
DOI: 10.1016/j.ymthe.2023.10.018

Molecular Therapy - Nucleic Acids

Author(s): Larissa Nassauer, Hinrich Staecker, Peixin Huang, Bryan Renslo, Madeleine Goblet, Jennifer Harre, Athanasia Warnecke, Juliane W Schott, Michael Morgan, Melanie Galla, Axel Schambach
Published in: Molecular Therapy Nucleic Acids, 2024, ISSN 2162-2531
Publisher: Nature Publishing Group
DOI: 10.1016/j.omtn.2024.102157